Related Experiment Videos
The effects of m-AMSA on rat isolated heart
Abstract:
m-AMSA (4'[9-acridinylamino]methansulphon-m-anisidide) is a new cytoxic agent now under clinical trial. We used the rat isolated perfused heart model in order to investigate the cardiac effects of m-AMSA. The results of the dose-response study indicate that m-AMSA has an acute moderate negative inotropic effect. The 90% effect (25% decrease in developed force compared to the control) was observed at drug concentration of 1.5 micrograms/ml. The refractory period (as measured by stimuli of twice diastolic threshold intensity) increased progressively as the drug concentration was increased (up to 2.5 micrograms/ml). Measurements of the strength-duration and strength-interval relationship showed that m-AMSA induced a significant reduction (P less than 0.005) in excitability and prolongation of refactoriness. We suggest that m-AMSA has a membranal cardiotoxic effect in addition to its known intracellular cytotoxic effect.
Insights
This study reveals that m-AMSA (4'[9-acridinylamino]methansulphon-m-anisidide) causes moderate negative inotropic effects and reduces cardiac excitability. These findings suggest a potential membranal cardiotoxic effect of this cytotoxic agent.
Area of Science:
- Pharmacology
- Cardiology
- Toxicology
Background:
- m-AMSA (4'[9-acridinylamino]methansulphon-m-anisidide) is a novel cytotoxic agent undergoing clinical trials.
- Understanding its potential cardiac side effects is crucial for patient safety.
Purpose of the Study:
- To investigate the cardiac effects of m-AMSA using an isolated perfused rat heart model.
- To determine the dose-response relationship and specific electrophysiological impacts of m-AMSA on the heart.
Main Methods:
- Utilized the rat isolated perfused heart model.
- Conducted dose-response studies to assess cardiac contractility (developed force).
- Measured refractory periods, strength-duration, and strength-interval relationships.
Main Results:
- m-AMSA demonstrated an acute, moderate negative inotropic effect, with a 25% decrease in developed force at 1.5 µg/ml.
- Progressive increases in drug concentration led to a prolonged refractory period.
- Significant reduction in cardiac excitability (P < 0.005) and refractoriness prolongation were observed.
Conclusions:
- m-AMSA exhibits a dose-dependent negative inotropic effect on the heart.
- The drug significantly reduces cardiac excitability and prolongs refractoriness.
- Evidence suggests m-AMSA may possess a membranal cardiotoxic effect, complementing its known intracellular cytotoxicity.